Loading CHMI-PA…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CHMI-PA","financials")Full statements spill as a table. For one cell: =jivedata("CHMI-PA","Revenue") or =jivedata("CHMI-PA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CHMI-PA • CIK 0001571776
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Interest Income, Operating | $49,985 | $55,798 | $61,095 | $62,071 |
| InterestExpenseOperating | — | $55,769 | $49,778 | $46,369 |
| Interest Income (Expense), Net | $-1,657 | $29 | $11,317 | $15,702 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-34,932 | $16,312 | $9,139 | $18,505 |
| Income Tax Expense (Benefit) | $523 | $4,102 | $2,197 | $1,909 |
| Cost of Goods and Services Sold | $11,248 | $12,418 | $9,275 | $9,386 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-35,455 | $12,210 | $6,942 | $16,596 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $-661 | $240 | $114 | $274 |
| Preferred Stock Dividends and Other Adjustments | $9,853 | $9,969 | $9,829 | $9,707 |
| Revenues, Net of Interest Expense | $-21,202 | $34,575 | $23,321 | $32,852 |
| Net Income (Loss) Available to Common Stockholders, Diluted | — | $2,079 | $-3,001 | $6,615 |
| General and Administrative Expense | $6,900 | $10,654 | $7,704 | $7,519 |
| Labor and Related Expense | — | $1,572 | $6,478 | $6,828 |
| Operating Expenses | $13,730 | $18,263 | $14,182 | $14,347 |
| Gain (Loss) on Sales of Mortgage Backed Securities (MBS) | $-36,315 | $-6,595 | $-6,045 | $-1,047 |
| Realized Investment Gains (Losses) | $23 | $504 | $0 | $0 |
| Gain (Loss) on Sale of Derivatives | $33,821 | $21,322 | $7,037 | $-366 |
| Unrealized Gain (Loss) on Derivatives | $-43,071 | $9,809 | $-39,767 | $-1,057 |
| Weighted Average Number of Shares Outstanding, Basic | 26,262,407 | 30,438,081 | 34,422,750 | 38,572,790 |
| Weighted Average Number of Shares Outstanding, Diluted | 26,293,903 | 30,440,349 | 34,422,750 | 38,572,790 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 181,942 | 268,421 | 1,528,829 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | $25 | $0 | $0 |
| Net Income (Loss) Available to Common Stockholders, Basic | $-44,647 | $2,054 | $-3,001 | $6,615 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted | — | $-25 | $0 | $0 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Debt Securities, Available-for-sale | $1,012,130 | $1,122,420 | $1,213,851 | $1,079,802 |
| Equity Method Investments | $253,629 | $233,658 | $214,831 | $211,105 |
| Cash and Cash Equivalents, at Carrying Value | $52,886 | $46,313 | $54,946 | $52,062 |
| Restricted Cash and Cash Equivalents | $16,441 | $24,446 | $7,523 | $25,434 |
| Derivative Asset | $19,504 | $30,048 | $14,757 | $1,622 |
| Assets | $1,392,992 | $1,491,175 | $1,540,556 | $1,397,544 |
| Noncontrolling Interest in Operating Partnerships | $2,899 | $3,280 | $2,491 | $2,481 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $258,375 | $233,622 | $238,532 | $228,924 |
| Securities Sold under Agreements to Repurchase | $903,489 | $1,077,257 | $1,137,200 | $1,008,738 |
| Derivative Liability | $16,617 | $3,869 | $2,275 | $3,739 |
| Notes Payable | $169,314 | $151,226 | $145,191 | $140,648 |
| Dividends Payable | $6,650 | $7,011 | $5,919 | $5,910 |
| Accrued Liabilities and Other Liabilities | $36,758 | $18,190 | $11,439 | $9,585 |
| Liabilities | $1,134,617 | $1,257,553 | $1,302,024 | $1,168,620 |
| Common Stock, Value, Issued | $305 | $322 | $373 | $378 |
| Additional Paid in Capital | $375,498 | $381,069 | $396,516 | $396,889 |
| Retained Earnings (Accumulated Deficit) | $-233,161 | $-249,643 | $-270,381 | $-278,445 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-2,545 | $-7,270 | $3,669 | $1,757 |
| Stockholders' Equity Attributable to Parent | $255,476 | $230,342 | $236,041 | $226,443 |
| Preferred Stock, Shares Authorized | — | 100,000,000 | 100,000,000 | 100,000,000 |
| Common Stock, Shares Authorized | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 |
| Common Stock, Shares, Issued | 30,019,969 | 31,625,073 | 36,739,538 | 36,947,394 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-35,455 | $12,210 | $6,942 | $16,596 |
| Net Cash Provided by (Used in) Operating Activities | $40,659 | $-4,691 | $19,097 | $23,218 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $3,773 | $1,432 | $-8,290 | $9,501 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $69,327 | $70,759 | $62,469 | $93,267 |
| Gain (Loss) on Sales of Mortgage Backed Securities (MBS) | $-36,315 | $-6,595 | $-6,045 | $-1,047 |
| Payments to Acquire Mortgage-backed Securities (MBS), Available-for-sale | $761,946 | $414,400 | $247,705 | $138,453 |
| Realized Investment Gains (Losses) | $23 | $504 | $0 | $0 |
| Proceeds from Sale of Mortgage-backed Securities (MBS), Available-for-sale | $585,617 | $195,132 | $99,844 | $96,090 |
| Proceeds from Sale of Mortgage Servicing Rights (MSR) | — | $13,308 | $0 | $0 |
| Gain (Loss) on Sale of Derivatives | $33,821 | $21,322 | $7,037 | $-366 |
| Payments for (Proceeds from) Derivative Instrument, Investing Activities | $-13,059 | $0 | $19,032 | $5,097 |
| Unrealized Gain (Loss) on Derivatives | $-43,071 | $9,809 | $-39,767 | $-1,057 |
| Net Cash Provided by (Used in) Investing Activities | $-104,054 | $-141,334 | $-66,651 | $75,859 |
| Accretion (Amortization) of Discounts and Premiums, Investments | $1,820 | $3,030 | $3,374 | $3,474 |
| Amortization of Debt Issuance Costs | $185 | $311 | $329 | $380 |
| Share-based Payment Arrangement, Noncash Expense | $468 | $496 | $287 | $206 |
| Increase (Decrease) in Accounts Receivable and Other Operating Assets | $1,613 | $-4,116 | $356 | $-3,183 |
| Increase (Decrease) in Due to Affiliates | $-81 | $-1,789 | $0 | $0 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $17,251 | $-18,568 | $-6,751 | $-8,441 |
| Payments for (Proceeds from) Derivative Instrument, Financing Activities | $-4,946 | $-24,462 | $0 | $-6,997 |
| Repayments of Bank Debt | $14,000 | $18,400 | $5,850 | $8,600 |
| Payments of Dividends | $31,211 | $28,168 | $28,658 | $26,259 |
| Proceeds from Issuance of Common Stock | $31,054 | $5,588 | $14,760 | $2,597 |
| Payments for Repurchase of Preferred Stock and Preference Stock | — | $9,438 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $67,168 | $147,457 | $39,264 | $-89,576 |
| Cash and Cash Equivalents, at Carrying Value | $52,886 | $46,313 | $54,946 | $54,344 |
| Restricted Cash and Cash Equivalents | $16,441 | $24,446 | $7,523 | $38,923 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $28,885 | $33,678 | $59,685 | $68,952 |
| Income Taxes Paid, Net | $56 | $64 | $49 | $42 |
| Payments of Ordinary Dividends, Common Stock | $6,650 | $7,011 | $5,919 | $4,186 |